retatrutide fatty liver study Weight loss drugs could help fight disease retatrutide nonalcoholic fatty liver disease

The Takeaway The menopause-related decline in estrogen can impact muscles and joints, skin, nails, the mouth, and bladder, which can negatively impact quality of life

Clegg, L

At 12mg, mean body weight reduction reached 24.2% with a favorable safety profile

A study in Cell Metabolism demonstrated that GIP receptor activation in adipose tissue can promote fat oxidation under certain conditions, and the combination of GIP and GLP-1 produces greater weight loss than either alone in both preclinical and clinical trials (2)

A confirmed diagnosis: Your prescription needs to be written for an FDA-approved use with the correct diagnosis code

Patients should monitor the injection site for any immediate reactions